About
Galvanize is a biomedical platform company that develops innovative energy-based medical device technologies, particularly focusing on Pulsed Electric Field (PEF) systems. These systems are designed to precisely target cells involved in disease processes, offering a safe alternative to traditional devices and drugs. The flagship product, the Aliya® PEF System, is aimed at therapeutic applications in oncology, chronic bronchitis, and drug delivery, with the goal of transforming energy into effective therapies for meaningful patient outcomes. The company emphasizes clinical validation through well-designed trials and collaborates closely with healthcare professionals to ensure patient access to its therapies. Recent milestones include participation in clinical trials for treating soft tissue lesions and non-small cell lung cancer. Galvanize's leadership team brings extensive experience in regulatory affairs, sales, marketing, and medical oversight, supported by a board with expertise in healthcare and biotechnology. The company was incubated by Apple Tree Partners and has notable investors, including Intuitive Surgical and T. Rowe Price.
Technologies
Keywords
Company Information
-
Employees 150
-
Founded 2015
-
Total Funding $200000000
Location
1531 Industrial Rd, San Carlos, California, United States, 94070-4111